APTO logo

Aptose Biosciences (APTO)

Profile

Full Name

Aptose Biosciences Inc.

Ticker Symbol

APTO

Exchange

NASDAQ

Country

Canada

IPO

March 16, 1992

Indexes

Not included

Employees

35

Key Details

Price

$2.02(-4.27%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00

Annual EPS

-$36.38(+84.00% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 28, 25 HC Wainwright & Co.
Buy
Feb 12, 25 HC Wainwright & Co.
Buy
Jan 10, 25 HC Wainwright & Co.
Buy
Dec 10, 24 HC Wainwright & Co.
Buy
Dec 3, 24 HC Wainwright & Co.
Buy
Nov 20, 24 HC Wainwright & Co.
Buy
Aug 11, 23 RBC Capital
Outperform
Aug 11, 23 Piper Sandler
Overweight
Aug 11, 23 Oppenheimer
Outperform
Aug 11, 23 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Aptose Biosciences?
  • Does Aptose Biosciences pay dividends?
  • What sector is Aptose Biosciences in?
  • What industry is Aptose Biosciences in?
  • What country is Aptose Biosciences based in?
  • When did Aptose Biosciences go public?
  • Is Aptose Biosciences in the S&P 500?
  • Is Aptose Biosciences in the NASDAQ 100?
  • Is Aptose Biosciences in the Dow Jones?
  • When was Aptose Biosciences's last earnings report?
  • When does Aptose Biosciences report earnings?
  • Should I buy Aptose Biosciences stock now?

What is the ticker symbol for Aptose Biosciences?

The ticker symbol for Aptose Biosciences is NASDAQ:APTO

Does Aptose Biosciences pay dividends?

No, Aptose Biosciences does not pay dividends

What sector is Aptose Biosciences in?

Aptose Biosciences is in the Healthcare sector

What industry is Aptose Biosciences in?

Aptose Biosciences is in the Biotechnology industry

What country is Aptose Biosciences based in?

Aptose Biosciences is headquartered in Canada

When did Aptose Biosciences go public?

Aptose Biosciences's initial public offering (IPO) was on March 16, 1992

Is Aptose Biosciences in the S&P 500?

No, Aptose Biosciences is not included in the S&P 500 index

Is Aptose Biosciences in the NASDAQ 100?

No, Aptose Biosciences is not included in the NASDAQ 100 index

Is Aptose Biosciences in the Dow Jones?

No, Aptose Biosciences is not included in the Dow Jones index

When was Aptose Biosciences's last earnings report?

Aptose Biosciences's most recent earnings report was on Apr 2, 2025

When does Aptose Biosciences report earnings?

The date for Aptose Biosciences's next earnings report has not been announced yet

Should I buy Aptose Biosciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page